From: Severity of SARS-CoV-2 infection in a hospital population: a clinical comparison across age groups
Subject | Age (y) | Sex | Symptoms | Cardiac involvement (Yes/No) | sHLH/MAS | Blood exams | Therapy | Length of hospitalization (days) | Outcome |
---|---|---|---|---|---|---|---|---|---|
1 | 2 | F | Fever, pharyngitis, anorexia, vomit, rash | No | No | CRP 10.4Â mg/dL, ESR 73Â mm/h, ferritin 207 ug/L, fibrinogen 609Â mg/L, proBNP II 4032Â ng/L, D-dimer 4549 ug/L, albumin 3.1Â g/dL | Oral steroid, IVIg, ASA, PPI, cefotaxime | 14 | Recovery without sequelae |
2 | 3 | M | Fever, conjunctival hyperemia, anorexia | No | No | CRP 12.9Â mg/dL, ferritin 536 ug/L, fibrinogen 333Â mg/L, TnT 3Â ng/L proBNP II 2998Â ng/L, D-dimer 5326 ug/L | IVIg, ASA, PPI, ceftriaxone | 11 | Recovery without sequelae |
3 | 8 | F | Fever, diarrhea, vomit, pharyngitis, oral mucositis, conjunctival hyperemia, abdominal pain, headache | No | No | CRP 9.17Â mg/dL, PCT 12.6 ug/L, ferritin 477 ug/L, fibrinogen 599Â mg/L, TnT 3Â ng/L proBNP II 118Â ng/L, D-dimer 4911 ug/L, albumin 2.99Â g/dL | IVIg, IV high-dose steroid, ASA, PPI, ceftriaxone, piperacillin/tazobactam | 14 | Recovery without sequelae |